<DOC>
	<DOCNO>NCT02174250</DOCNO>
	<brief_summary>The purpose study test whether Rifampin affect blood level istradefylline human . Rifampin could possibly decrease istradefylline level .</brief_summary>
	<brief_title>The Effect Rifampin Metabolism Istradefylline Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Istradefylline</mesh_term>
	<criteria>Healthy nonsmoking male postmenopausal female subject Body Mass Index : 18.035.0 kg/m2 , inclusive Subjects must take drug moderate potent inhibitor CYP3A4 CYP1A2 . Subjects without clinically significant medical history judgment investigator Subjects without clinically significant laboratory ECG abnormalities Females pregnant lactate Administration investigational drug within 30 day 5 elimination halflives investigational drug , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study ; Known history treatment drug alcohol addiction within previous 12 month ; Subjects average alcohol intake 2 unit per day 14 unit per week 48 hour prior istradefylline dose Day 1 . One unit alcohol Â½ pint beer ( 285 mL ) 1 glass spirit ( 25 mL ) 1 glass wine ( 125 mL ) ; Donated lose &gt; 500 mL blood within 3 month prior istradefylline dose Day 1 Period 1 ; Positive test result human immunodeficiency virus ( HIV ) Hepatitis B surface antigen , Hepatitis C ; Positive test result drug abuse screening ; Unable , unwilling tolerate multiple venipuncture ; Difficulty fast eat standard meal provide ; Use tobacco nicotinecontaining product within 90 day study start Followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>PD</keyword>
</DOC>